Arterium

Name

Arterium

Legal name

Corporation Arterium (Корпорація «Артеріум»)

Website

https://arterium.ua

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Tender & Government Supply Markets (HLAIABAM)

akta.pro secondary industry

Health Supply Chain, Procurement & Access to Medicines (BPADAIAI)

Keywords

• Pharmaceutical manufacturing
• Prescription medicines
• Dietary supplements
• Veterinary pharmaceuticals
• Dermocosmetic products

Headquarters

HQ city

Kyiv

HQ country

Ukraine

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products Sales: Sale of prescription medicines, over-the-counter drugs, and medical devices through pharmacy chains, hospitals, and distribution networks in Ukraine and internationally. The company launched 25 new products in 2025 and has over 239 products in its portfolio over 20 years.
2. Dermocosmetics and Dietary Supplements: Sale of dermocosmetic products (KERASKIN, KERAKAP) and dietary supplements (Sedavit, Sofinel, Resisto Hot) through pharmacies and online platforms.
3. Veterinary Products: Sale of veterinary medicines and health products for animals including Alprobic Premium, with exclusive distribution by Kyivmedpreparat in Ukraine.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Arterium is a Ukrainian pharmaceutical corporation that manufactures and distributes a broad portfolio of prescription medicines, over-the-counter drugs, dietary supplements, veterinary products, dermocosmetics, and medical devices. The company operates GMP-certified production facilities through subsidiaries PJSC Halychpharm (Lviv) and Kyivmedpreparat, producing sterile infusion solutions, ampoules, tablets, ointments, and capsules for Ukrainian and international regulated markets including Australia and Singapore.

Product overview

Arterium Corporation is a Ukrainian pharmaceutical company operating under a multi-product portfolio architecture. The company produces prescription drugs (including infusion solutions like Linezolidin, Sodium Chloride, Ornizol, Osmolife), over-the-counter medicines, dietary supplements (Sedavit product line including Sedavit Uno, Sofinel, Resistol Hot), veterinary products (Alprobic Premium, Dia Dog & Ket), medical devices, and cosmetic products (KERASKIN line, Kerakap). The portfolio encompasses over 35 antibiotic products, products for nervous system support, metabolism, cardiovascular, dermatological, respiratory, digestive, pain management, and musculoskeletal conditions. Manufacturing facilities include Halychpharm (Lviv) and Kyivmedpreparat with GMP-certified production lines. The company exports to international markets including Australia, Singapore, Kazakhstan, and Uzbekistan.

Differentiator

Problem solved

Functional benefit

Brands

• Resistol (Резістол): Product line for cold and flu symptoms, including oral drops, tablets, and hot drink powder (Resistol Hot). Launched in 2014.
• Sedavit (Седавіт)
• KERASKIN (КЕРАСКІН)
• Sofinel (Софінель)
• Alprobic Premium (Альпробік преміум)
• Linezolidin (Лінезолідин)
• Urolesan (УРОЛЕСАН)
• Renial (Реніаль)
• Neuroxon (Нейроксон)

Products and services

• Linezolidin (ЛІНЕЗОЛІДИН) Prescription antibacterial infusion solution containing linezolid 2mg/ml for treatment of nosocomial pneumonia, community-acquired pneumonia, and skin and soft tissue infections.
• Sodium Chloride (НАТРІЮ ХЛОРИД) 9mg/ml sodium chloride infusion solution for replenishing fluid deficiency and as a solvent for compatible drugs.
• Ornizol (ОРНІЗОЛ) 5mg/ml ornidazole infusion solution from imidazole derivatives for anaerobic systemic infections including sepsis, meningitis, peritonitis, and surgical infection prevention.
• Osmolife (ОСМОЛАЙФ) Electrolyte infusion solution with sodium, potassium, magnesium, calcium chlorides, sodium acetate, and L-malic acid for replacement of interstitial fluid losses in isotonic dehydration.
• KERASKIN (КЕРАСКІН) Specialized dermocosmetic product line for daily care of dry, sensitive, and atopy-prone skin, comprising cream in two dosages, milk, and cleansing gel providing 48-hour skin moisturizing.
• Sedavit Uno (Седавіт Уно) Plant-based dietary supplement in extended-release tablet form providing 24-hour calming effect, using the Relissa component from Indena (Italy) combined with valerian, hawthorn, St. John's wort, peppermint, and hop extracts.
• Sofinel (Софінель) Dietary supplement in capsule form containing encapsulated saffron extract Safr'Inside 30mg for relieving anxiety and psychoemotional tension; utilizes Phytosome technology that maintains 10x higher concentration of active components (safranal and crocins) compared to non-encapsulated extracts.
• Alprobic Premium Comprehensive dietary drink for calves with diarrhea that normalizes gastrointestinal tract function and electrolyte balance, stabilizes natural intestinal microflora, and maintains calf growth during diarrhea treatment; manufactured using encapsulated ingredients from German supplier SUPPLEXAN.
• Resistol Hot (Резістол Хот)

Quantifiable outcome

• 25 new products launched in 2025 on Ukrainian and international markets
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

19 partnerships are on record, tiered minor, flagship and core.

• Shevchenkivskyi District State Administration (Kyiv)minorGTM or Marketing Partner · 19 September 2025Head of Shevchenkivskyi District State Administration visited Arterium on Pharmaceutical Workers' Day, recognizing the company's contributions to the pharmaceutical industry and Kyiv community development.
• Ukrainian Ministry of HealthflagshipStrategic or Co-development Partner · 23 October 2024Arterium participated in the conference 'European Integration of Ukraine: Healthcare' organized by the Ministry of Health of Ukraine. Director Serhiy Sur from Arterium LTD shared insights on legislative implementation of EU integration in the pharmaceutical sector.
• UNBROKEN Rehabilitation Center in LvivcoreGTM or Marketing PartnerArterium participates in veteran reintegration projects at UNBROKEN center, providing information about employment opportunities in the pharmaceutical sector and veteran support programs.
• VeteranHubcoreGTM or Marketing PartnerArterium supported the stable operation of VeteranHub during funding crisis, helping maintain free legal and psychological support services for veterans and their families.
• Lviv Geriatric Boarding HouseminorGTM or Marketing PartnerFor five years, Arterium has supported the Lviv Geriatric Boarding House, providing materials for equipping resident rooms. The facility houses 250 elderly residents and persons with disabilities.
• Ukrainian Student LeagueminorGTM or Marketing PartnerArterium participated as speaker in student forum 'Fundraising: From Start to Finish' organized by Ukrainian Student League and Kyiv Youth Center, engaging 100 student leaders from 36 universities.
• Lviv National University named after Ivan Franko - Department of Organic ChemistrycoreStrategic or Co-development PartnerJoint implementation of 'Chemistry by Touch' educational project for schoolchildren interested in chemistry and pharmacy. Project won Arterium's grant competition within Business School for teachers, with 25 students from various regions participating.
• Lviv Regional Minor Academy of SciencescoreStrategic or Co-development PartnerCooperation with Lviv Regional Minor Academy of Sciences in implementing the 'Chemistry by Touch' educational project supporting youth interest in pharmaceutical sciences.
• SUPPLEXAN GmbH & Co.KG (Germany)coreStrategic or Co-development PartnerGerman partner supplying encapsulated ingredients for Alprobic Premium veterinary product, ensuring European quality standards. SUPPLEXAN provides formulation expertise for calf diarrhea treatment products.
• Kyivmedpreparat (Exclusive Ukrainian Distributor)coreChannel Partner/ Reseller/ DistributorKyivmedpreparat serves as exclusive distributor of Alprobic Premium veterinary product in Ukraine, complementing Arterium's veterinary portfolio expansion.
• Veteran MediaminorGTM or Marketing PartnerMedia organization co-organizing veteran employment and reintegration events with Arterium participation.
• Lviv Service Center for VeteransminorGTM or Marketing PartnerGovernment service co-organizing veteran opportunities events including training, retraining, and employment programs.
• HR Office of Lviv City CouncilminorGTM or Marketing PartnerCity council department collaborating on veteran reintegration project 'Opportunities: Training, Retraining, Employment'.
• European Commission RepresentativesflagshipStrategic or Co-development PartnerBorys Falatar, representative of the European Health Emergencies Preparedness and Response Authority (HERA), discussed EU interest in cooperation with Ukrainian pharmaceutical manufacturers for building sustainable medicine supply systems.
• State Expert Center of the Ministry of Health of UkrainecoreStrategic or Co-development PartnerState regulatory body representatives visited Arterium's Research Center to understand product development processes, building trust and quality partnerships between business and government for patient health.
• Verkhovna Rada Committee on National Health ProtectionflagshipStrategic or Co-development PartnerMykhailo Radutsky, Chairman of the Committee, noted that 80% of Association Agreement obligations with the EU in healthcare have been fulfilled.
• Activ'Inside (France)coreStrategic or Co-development PartnerFrench company specializing in producing saffron extracts with maximum concentration of active components using Phytosome technology. Provides encapsulated saffron extract Safr'Inside for Sofinel dietary supplement.
• Indena (Italy)coreStrategic or Co-development PartnerItalian company that developed Relissa ingredient using proprietary Phytosome technology for Sedavit Uno dietary supplement with 24-hour prolonged action.
• J.S. Hamilton Laboratory (Eastern Europe)coreTechnology or IntegrationLeading Eastern European laboratory that tested KERASKIN dermocosmetic products under dermatological and pediatric control, confirming safety for adults and children from birth.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Regional players

• Polpharma: Polish pharmaceutical manufacturer of generics and APIs with a strong CEE distribution footprint. Comparable to Arterium in Eastern European positioning, generic-finished dosage forms, and tender market access, though primarily Poland-anchored.

Broad incumbents

• Gedeon Richter: Hungarian-headquartered pharmaceutical group with branded generics, biosimilars, and proprietary CNS products across the CEE and CIS region. Overlaps with Arterium in CEE generics distribution, hospital channel strength, and regional manufacturing footprint.
• Stada Arzneimittel: German-headquartered generics and consumer healthcare company with broad European finished-dosage-form portfolio. Comparable to Arterium in generics manufacturing plus consumer health/OTC extensions, though operating across a much wider European footprint.
• Actavis (Teva generic franchise legacy): Global generic pharmaceuticals business operating within Teva, with significant manufacturing and tender-market presence in CEE. Comparable to Arterium in finished-dosage-form generics, biosimilars, and emerging-market tender participation, though at much larger scale.

Direct peers

• KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with vertically integrated API-to-finished-product operations and a heavy presence in Central and Eastern European hospital tenders. Comparable manufacturing breadth, generic-portfolio depth, and emerging-markets tender strategy to Arterium.
• Micro Labs: Indian generic manufacturer with broad finished dosage forms and growing presence in regulated tender markets including Australia. Comparable to Arterium in expanding into Australia/Singapore tenders and in vertically integrated generics manufacturing.
• Egis Pharmaceuticals: Hungarian pharmaceutical manufacturer producing generic and branded finished dosage forms with deep presence in CEE/CIS hospital tenders. Comparable product breadth, dosage-form capabilities, and Eastern European distribution profile to Arterium.
• Darnitsa: One of Ukraine's largest pharmaceutical manufacturers with a broad portfolio of finished dosage forms, hospital infusion solutions, and generics. Directly comparable to Arterium in therapeutic coverage, manufacturing footprint, and Ukrainian hospital tender participation; notably co-searched with Arterium in 2025 law enforcement action.
• Farmak: Leading Ukrainian pharmaceutical manufacturer producing generic and branded finished dosage forms across cardiovascular, anti-infective, and metabolic therapies. Closest domestic competitor to Arterium in scale, GMP-certified production, and participation in Ukrainian and CIS hospital procurement.
• Zentiva: European generics specialist headquartered in Prague with broad finished-dosage-form portfolio (tablets, injectables, semisolid) across cardiovascular, anti-infectives, and CNS. Comparable to Arterium in targeting Eastern European tender markets and offering vertically integrated generic manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ARTERIUM.corp

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arterium